Cara Caasi-Singh

Chief Executive Officer/Network Expansion Lead

Ascend Clinical Research, UK

Cara is a UK based healthcare leader, entrepreneur and the CEO & Co-founder of Ascend Clinical Research Limited.
has been in healthcare since 2011 and worked in various positions in clinical research since 2018.
Her work in cancer at Cambridge University Hospitals ignited her passion to transition in clinical research and contribute to make a difference in developing better treatments for patients and alleviate the
burden of disease, witnessing breakthrough results and development of positive outcomes fuelled her commitment to evolve in the clinical research space, engaging in multi therapy research practice.
Awarded UK NIHR Cancer Research Awardee in 2020.
She has previously led the establishment and management of 1st commercial psychedelic trial-focused facility in Europe
*UK NIHR Cancer Research Awardee 2020
She leads Ascend withthe vision of quality with excellence in th eexecution of trial delivery.
Under her leadership the organization has won as best Clinical Trials Partner UK and Patient Care Excellence at the GHP Healthcare and Pharma Awards.
Her strategic focus centres on expanding patient access to trials, building agile site networks and guiding the delivery of breakthrough treatments.